Wells Fargo Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...
Business Wire12d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and ...
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
RBC Capital Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Yahoo Finance12d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases.
Yahoo Finance12d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Their team has made great strides in designing and developing an enzymatic DNA synthesis platform with exciting technical advantages over traditional chemical synthesis," said Trey Martin, CEO of ...